Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome

Original Article

F.L. Kuang, F. Legrand, M. Makiya, J. Ware, L. Wetzler, T. Brown, T. Magee, B. Piligian, P. Yoon, J.H. Ellis, X. Sun, S.R. Panch, A. Powers, H. Alao, S. Kumar, M. Quezado, L. Yan, N. Lee, R. Kolbeck, P. Newbold, M. Goldman, M.P. Fay, P. Khoury, I. Maric, and A.D. Klion

N Engl J Med 2019;380:1336-1346

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
04/03/2019
Course expires: 
04/04/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, April 4, 2021 - 11:59pm.